Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chase L Beisel

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Microlife|May 16, 2025
Disparate mechanisms counteract extraneous CRISPR RNA production in type II-C CRISPR-Cas systemsMaximilian Feussner, Angela Migur, Alexander Mitrofanov, et al.
Journal of Visualized Experiments : Jove|August 29, 2022
Cell-Free Protein Synthesis from Exonuclease-Deficient Cellular Extracts Utilizing Linear DNA TemplatesMahnaz Sabeti Azad, Angelo Cardoso Batista, Jean-Loup Faulon, et al.
Plos One|May 1, 2020
Tunable self-cleaving ribozymes for modulating gene expression in eukaryotic systemsThomas Jacobsen, Gloria Yi, Hadel Al Asafen, et al.
Angewandte Chemie (International Ed. in English)|August 28, 2015
Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editingWujin Sun, Wenyan Ji, Jordan M Hall, et al.
Brain Research. Brain Research Protocols|February 20, 2002
Cochlear whole mount in situ hybridization: identification of longitudinal and radial gradientsTiffany N Judice, Nathan C Nelson, Chase L Beisel, et al.
Nature|January 4, 2023
RNA targeting unleashes indiscriminate nuclease activity of CRISPR-Cas12a2Jack P K Bravo, Thomson Hallmark, Bronson Naegle, et al.
ACS Synthetic Biology|April 12, 2021
<i>In Situ</i> Biomanufacturing of Small Molecules in the Mammalian Gut by Probiotic <i>Saccharomyces boulardii</i>Deniz Durmusoglu, Ibrahim S Al'Abri, Scott P Collins, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Target RNA-triggered CRISPR-Cas12a2 Preferentially Cleaves Collateral DNA over RNASobita Kunwar, Thomson Hallmark, Sudeshna Manna, et al.
Nucleic Acids Research|June 16, 2026
Target RNA-triggered CRISPR-Cas12a2 preferentially cleaves collateral DNA over RNASobita Kunwar, Thomson Hallmark, Sudeshna Manna, et al.
Nucleic Acids Research|November 28, 2023
Interrogating two extensively self-targeting Type I CRISPR-Cas systems in Xanthomonas albilineans reveals distinct anti-CRISPR proteins that block DNA degradationFranziska Wimmer, Frank Englert, Katharina G Wandera, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Microlife|May 16, 2025
Disparate mechanisms counteract extraneous CRISPR RNA production in type II-C CRISPR-Cas systemsMaximilian Feussner, Angela Migur, Alexander Mitrofanov, et al.
Journal of Visualized Experiments : Jove|August 29, 2022
Cell-Free Protein Synthesis from Exonuclease-Deficient Cellular Extracts Utilizing Linear DNA TemplatesMahnaz Sabeti Azad, Angelo Cardoso Batista, Jean-Loup Faulon, et al.
Plos One|May 1, 2020
Tunable self-cleaving ribozymes for modulating gene expression in eukaryotic systemsThomas Jacobsen, Gloria Yi, Hadel Al Asafen, et al.
Angewandte Chemie (International Ed. in English)|August 28, 2015
Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editingWujin Sun, Wenyan Ji, Jordan M Hall, et al.
Brain Research. Brain Research Protocols|February 20, 2002
Cochlear whole mount in situ hybridization: identification of longitudinal and radial gradientsTiffany N Judice, Nathan C Nelson, Chase L Beisel, et al.
Nature|January 4, 2023
RNA targeting unleashes indiscriminate nuclease activity of CRISPR-Cas12a2Jack P K Bravo, Thomson Hallmark, Bronson Naegle, et al.
ACS Synthetic Biology|April 12, 2021
<i>In Situ</i> Biomanufacturing of Small Molecules in the Mammalian Gut by Probiotic <i>Saccharomyces boulardii</i>Deniz Durmusoglu, Ibrahim S Al'Abri, Scott P Collins, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Target RNA-triggered CRISPR-Cas12a2 Preferentially Cleaves Collateral DNA over RNASobita Kunwar, Thomson Hallmark, Sudeshna Manna, et al.
Nucleic Acids Research|June 16, 2026
Target RNA-triggered CRISPR-Cas12a2 preferentially cleaves collateral DNA over RNASobita Kunwar, Thomson Hallmark, Sudeshna Manna, et al.
Nucleic Acids Research|November 28, 2023
Interrogating two extensively self-targeting Type I CRISPR-Cas systems in Xanthomonas albilineans reveals distinct anti-CRISPR proteins that block DNA degradationFranziska Wimmer, Frank Englert, Katharina G Wandera, et al.
Pageof 12